Conservative Site-specific Recombination and Phase Variation
Homologous Recombination
CRISPR/Cas9 Genome Editing
CRISPR
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 29, 2025

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
Published on: September 25, 2019
José María Martín-Fernández1, Aarne Fleischer1,2, Sara Vallejo-Diez2
1Karuna Good Cells Technologies SL, Vitoria-Gasteiz, Álava, Spain.
Researchers developed a more efficient transcription activator-like effector nuclease (TALEN) system for gene editing. This novel TALEN approach streamlines cell selection, accelerating stem cell and regenerative medicine research.
09:51Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
Published on: February 2, 2016
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: